$1.98B
$43.9 Million
0.0% of portfolio
320
Q4 2025
Added 18.52%
$295M
$3.18 Million
0.0% of portfolio
320
Q4 2025
Added 39.13%
$200M
$11.6 Million
0.0% of portfolio
320
Q4 2025
Added 9.97%
$0
$3.36 Million
0.0% of portfolio
321
Q4 2025
Added 165.29%
$7.37B
$88.9 Million
0.0% of portfolio
322
Q4 2025
Added 24.81%
$403M
$2.44 Million
0.0% of portfolio
322
Q4 2025
Added 1,433.33%
$418B
$47.5 Million
0.0% of portfolio
324
Q4 2025
Added 107.69%
$1.37B
$5.07 Million
0.0% of portfolio
328
Q4 2025
Added 53.99%
$119M
$1.29 Million
0.0% of portfolio
329
Q4 2025
Reduced 70.99%
$1.4B
$16.7 Million
0.0% of portfolio
329
Q4 2025
Reduced 60.31%
Diebold Nixdorf Inc Com Shs
-
$22.3 Million
0.0% of portfolio
-
Q4 2025
Added 26.54%
$0
$29.1 Million
0.0% of portfolio
329
Q4 2025
Reduced 62.18%
$632M
$8.63 Million
0.0% of portfolio
330
Q4 2025
Reduced 17.09%
$397M
$3.45 Million
0.0% of portfolio
330
Q4 2025
Added 126.03%
$0
$30.7 Million
0.0% of portfolio
330
Q3 2025
Reduced 15.38%
$4.61B
$84.2 Million
0.0% of portfolio
330
Q4 2025
Added 19.57%
Spyre Therapeutics Inc Com New
-
$10.8 Million
0.0% of portfolio
-
Q4 2025
Added 58.65%
Weg Sa Brazil Sponsored Adr
-
$2.98 Million
0.0% of portfolio
-
Q4 2025
Reduced 60.76%
$1.18B
$15.8 Million
0.0% of portfolio
331
Q3 2025
Added 1.85%
$2.71B
$15.2 Million
0.0% of portfolio
331
Q4 2025
Added 117.76%
-
$7.41 Million
0.0% of portfolio
-
Q4 2025
Added 69.39%
$0
$69.4 Million
0.0% of portfolio
332
Q2 2025
Reduced 2.92%
$439M
$4.84 Million
0.0% of portfolio
333
Q3 2025
Reduced 4.03%
-
$2.73 Million
0.0% of portfolio
-
Q4 2025
New
$3.94B
$21.8 Million
0.0% of portfolio
334
Q4 2025
Reduced 9.73%
-
$20.4 Million
0.0% of portfolio
-
Q4 2025
Added 351.35%
$4.15B
$33.7 Million
0.0% of portfolio
335
Q4 2025
Added 47.58%
Nano Nuclear Energy Inc Com
-
$8.07 Million
0.0% of portfolio
-
Q4 2025
Added 34.4%
Sable Offshore Corp Com Shs
-
$3.03 Million
0.0% of portfolio
-
Q4 2025
Reduced 54.78%
$3.37B
$23.9 Million
0.0% of portfolio
337
Q4 2025
Added 4.66%
$370M
$1.87 Million
0.0% of portfolio
337
Q4 2025
New
Sage Therapeutics Inc Com Cvr From 78667 J108
-
$0
0.0% of portfolio
-
Q3 2025
New
$0
$57.1 Million
0.0% of portfolio
338
Q3 2025
Reduced 10.34%
$1.92B
$27.8 Million
0.0% of portfolio
340
Q4 2025
Added 34.92%
$2.69B
$21.6 Million
0.0% of portfolio
341
Q4 2025
Added 25.37%
-
$15.6 Million
0.0% of portfolio
-
Q4 2025
Added 1.49%
Tuhura Biosciences Inc Com
-
$258,000
0.0% of portfolio
-
Q4 2025
New
Rapport Therapeutics Inc Com
-
$10.4 Million
0.0% of portfolio
-
Q4 2025
Reduced 3.39%
$0
$43.1 Million
0.0% of portfolio
342
Q2 2025
Added 44.92%
$187M
$3.73 Million
0.0% of portfolio
345
Q4 2025
Reduced 52.28%
$202M
$2.09 Million
0.0% of portfolio
346
Q4 2025
Reduced 73.93%
$173M
$2.95 Million
0.0% of portfolio
346
Q4 2025
Added 11.97%
$1.63B
$16.3 Million
0.0% of portfolio
347
Q4 2025
Added 54.22%
$124M
$829,000
0.0% of portfolio
347
Q4 2025
New
$0
$15.3 Million
0.0% of portfolio
347
Q4 2025
Added 519.64%
$139M
$4.68 Million
0.0% of portfolio
347
Q4 2025
Added 24.37%
Orrstown Finl Svcs Inc Com
-
$12.3 Million
0.0% of portfolio
-
Q4 2025
Added 4.52%
$34.7B
$2.79 Million
0.0% of portfolio
348
Q3 2025
Added 82.2%
$1.88B
$3.12 Million
0.0% of portfolio
350
Q4 2025
New
$2.7B
$4.99 Million
0.0% of portfolio
350
Q2 2025
Reduced 96.66%